“…The primary event is brief and triggers secondary processes, many of which remain active for hours to days, and contribute to a number of brain pathologies, including neurovascular dysfunction, tissue loss, and neurocognitive impairments (Floyd and Lyeth, 2007;Giri et al, 2000;Hicks et al, 2010;Meaney and Smith, 2011;Ray et al, 2002;Smith et al, 2010;Stoica and Faden, 2010;Werner and Engelhard, 2007;Yakovlev and Faden, 2001). A number of molecular mechanisms that underlie these secondary processes have been identified in rodent models and clinical studies, and represent potential targets for therapeutic intervention (Beauchamp et al, 2008;Fedor et al, 2010;Hayes et al, 2009;Huh and Raghupathi, 2009;Ottens et al, 2010;Saatman et al, 2010;Shellington et al, 2011;Sullivan et al, 2011). These include oxidative damage resulting from increased production of reactive oxygen species (ROS) and reduced glutathione levels, inflammation resulting from local and infiltrating cells, mitochondrial dysfunction, and activation of apoptotic cell death cascades (Babikian et al, 2010;Fan et al, 2003;Hall et al, 2010;Hayes and Dixon, 1994;Igarashi et al, 2001;Kelley et al, 2007;Lifshitz et al, 2003).…”